LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
CAS Number
862507-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7070551 Inquire
Recombinant Sinapis alba Cytochrome P450 79B1 (CYP79B1), partial
Ask
View Details 
GTR15192443 1 Vial
Lentiviral mouse Abcb5 shRNA (UAS) - Lentiviral mouse Abcb5 shRNA (UAS, RFP) (25)
Ask
View Details MBS6376048-01 0.1 mL
DFF45 (DNA Fragmentation Factor Subunit alpha, DNA Fragmentation Factor 45kD Subunit, DFF-45, Inhibitor of CAD, ICAD, DFFA, DFF1, H13) (MaxLight 650)
Ask
View Details 
MBS6376048-02 5x 0.1 mL
DFF45 (DNA Fragmentation Factor Subunit alpha, DNA Fragmentation Factor 45kD Subunit, DFF-45, Inhibitor of CAD, ICAD, DFFA, DFF1, H13) (MaxLight 650)
Ask
View Details 